Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
Marek Samec, Alena Líšková, Lenka Koklesová, et al.
Cancers (2021) Vol. 13, Iss. 1, pp. 130-130
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 152
The Hallmarks of Flavonoids in Cancer
Luis Gustavo Saboia Ponte, Isadora Carolina Betim Pavan, Mariana Camargo Silva Mancini, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 2029-2029
Open Access | Times Cited: 116
Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma
Zhihua Ou, Shitong Lin, Jiaying Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 74
Date Palm Fruit (Phoenix dactylifera) and Its Promising Potential in Developing Functional Energy Bars: Review of Chemical, Nutritional, Functional, and Sensory Attributes
Hassan Barakat, Hani A. Alfheeaid
Nutrients (2023) Vol. 15, Iss. 9, pp. 2134-2134
Open Access | Times Cited: 42
Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 155-176
Open Access | Times Cited: 101
Flavonoids against non-physiologic inflammation attributed to cancer initiation, development, and progression—3PM pathways
Peter Kubatka, Alena Mazuráková, Marek Samec, et al.
The EPMA Journal (2021) Vol. 12, Iss. 4, pp. 559-587
Open Access | Times Cited: 67
An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor
Yukari Shirai, Christalle C. T. Chow, Gouki Kambe, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2813-2813
Open Access | Times Cited: 57
N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop
Qingbin Yang, Xuetao Lei, Jiayong He, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 35
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 34
Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells – A potential contribution to the predictive, preventive, and personalized medicine
Alena Mazuráková, Lenka Koklesová, Sandra Hurta Csizmár, et al.
Journal of Advanced Research (2023) Vol. 55, pp. 103-118
Open Access | Times Cited: 30
Targeting the Metabolic Paradigms in Cancer and Diabetes
Mira Bosso, Dania Haddad, Ashraf Al Madhoun, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 211-211
Open Access | Times Cited: 13
Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy
Xuan Ni, Chengpiao Lu, Guo-qiang Xu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1533-1555
Closed Access | Times Cited: 11
Administration route-dependent pharmacokinetic and biopharmaceutical features of steppogenin
Ji‐Hoon Lee, Minyeong Pang, So Yeon Jeon, et al.
Journal of Pharmaceutical Investigation (2025)
Closed Access | Times Cited: 1
Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs
Kevin Zhai, Alena Mazuráková, Lenka Koklesová, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1841-1841
Open Access | Times Cited: 55
Natural Compounds in Glioblastoma Therapy: Preclinical Insights, Mechanistic Pathways, and Outlook
Kevin Zhai, Manaal Siddiqui, Basma Abdellatif, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2317-2317
Open Access | Times Cited: 43
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
Quercetin potential effects against SARS‐CoV‐2 infection and COVID‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α (HIF‐1α)
Hamidreza Zalpoor, Maryam Bakhtiyari, Mahsa Liaghat, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2679-2682
Open Access | Times Cited: 33
Multifunctional green synthesized Cu–Al layered double hydroxide (LDH) nanoparticles: anti-cancer and antibacterial activities
Mahsa Kiani, Mojtaba Bagherzadeh, Amir Mohammad Ghadiri, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Potential Strategies for Overcoming Drug Resistance Pathways Using Propolis and Its Polyphenolic/Flavonoid Compounds in Combination with Chemotherapy and Radiotherapy
Nada Oršolić, Maja Jazvinšćak Jembrek
Nutrients (2024) Vol. 16, Iss. 21, pp. 3741-3741
Open Access | Times Cited: 7
Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications
Sujit Kumar Debnath, Monalisha Debnath, Arnab Ghosh, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 6
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Advancements in clinical translation of flavonoid nanoparticles for cancer treatment
Tripti Sharma, Deepika Singh, Aastha Mahapatra, et al.
OpenNano (2022) Vol. 8, pp. 100074-100074
Open Access | Times Cited: 25
MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway
Sathan Raj Natarajan, Lavanya Ponnusamy, Ravi Manoharan
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 7, pp. 119242-119242
Open Access | Times Cited: 24
A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials
Yasanandana Supunsiri Wijayasinghe, Meenakshi P. Bhansali, Maheshkumar R. Borkar, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3706-3728
Closed Access | Times Cited: 23
Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling
Peter Kubatka, Lenka Koklesová, Alena Mazuráková, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 87-113
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top